Abstract
Objective Female reproductive health comprises adequate oocyte quality and quantity, normal fecundability, a normal course of pregnancy, and the delivery of healthy offspring. General aging patterns and the maintenance of somatic health have been associated with female reproductive health. However, it is unknown whether better long-term somatic maintenance is directly related to reproductive outcomes, and whether there is a shared genetic predisposition underlying both somatic and reproductive aging. Here we investigate whether reproductive health is related to female lifespan or familial longevity.
Design Observational study
Subjects 10,255 female members of a multigenerational historical cohort (1812-1910), the LINKing System for historical family reconstruction (LINKS) and 1,258 females from 651 long-lived families in the Leiden Longevity Study.
Main outcome measures The association between reproductive characteristics and longevity was studied both on an individual and familial level. Individual survival was studied in relation to age at last childbirth and total number of children. Familial longevity was studied through parental survival and related to age at last childbirth, total number of children and a polygenic risk score (PRS) for age at menopause.
Results Females giving birth to their last child at a higher age lived longer: for each year increase in the age of the birth of the last child, a woman’s lifespan increased with 0.06 years (22 days) (p<0.005). Females who lived to be in the top 10% survivors of their birth cohort (n=2,241, 21.9%) on average gave birth to their last child at a 1% later age than the remaining cohort (IRR=1.01, p<0.005).
Females with 1 or 2 long-lived parents did not have a higher mean age of last childbirth. There was neither a significant association between an increasing number of long-lived ancestral family members (familial longevity), nor the PRS.
Conclusion Female reproductive health associates with a longer lifespan and with survival to more extreme ages (longevity). The heritable component in familial longevity, however, does not associate to extended reproductive health and the PRS underlying age at menopause does not explain familial longevity. Other factors in somatic maintenance that support a longer lifespan are likely to have an impact on reproductive health.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The construction and maintenance of the LLS data has received funding from the European Union's Seventh Framework Programme (FP7/2007-2011) under grant agreement number 259679. This study was further supported by BBMRI-NL, a Research Infrastructure financed by the Dutch government (NWO 184.021.007 and 184.033.111), and the VOILA consortium (ZonMw; 457001001). Niels van den Berg was funded by the Netherlands Organization for Scientific Research, domain Health Research and Medical Sciences (09120012010052).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
In accordance with the Declaration of Helsinki, we obtained informed consent from all participants prior to their the study entry. Good clinical practice guidelines were maintained. The study protocol was approved by the ethical committee of the Leiden University Medical Center before the start of the study (P01.113).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
